What Should a Psychiatrist Know About Genetics? Review and Recommendations From the Residency Education Committee of the International Society of Psychiatric Genetics.
paper
Cited
Public
- Authors
- Nurnberger, John I; Austin, Jehannine; Berrettini, Wade H; Besterman, Aaron D; DeLisi, Lynn E; Grice, Dorothy E; Kennedy, James L; Moreno-De-Luca, Daniel; Potash, James B; Ross, David A; Schulze, Thomas G; Zai, Gwyneth
- Year
- 2018
- Journal
- The Journal of clinical psychiatry
- PMID
- 30549495
- DOI
- 10.4088/JCP.17nr12046
- PMCID
- PMC6480395
The International Society of Psychiatric Genetics (ISPG) created a Residency Education Committee with the purpose of identifying key genetic knowledge that should be taught in psychiatric training programs. Thirteen committee members were appointed by the ISPG Board of Directors, based on varied training, expertise, gender, and national origin. The Committee has met quarterly for the past 2 years, with periodic reports to the Board and to the members of the Society. The information summarized includes the existing literature in the field of psychiatric genetics and the output of ongoing large genomics consortia. An outline of clinically relevant areas of genetic knowledge was developed, circulated, and approved. This document was expanded and annotated with appropriate references, and the manuscript was developed. Specific information regarding the contribution of common and rare genetic variants to major psychiatric disorders and treatment response is now available. Current challenges include the following: (1) Genetic testing is recommended in the evaluation of autism and intellectual disability, but its use is limited in current clinical practice. (2) Commercial pharmacogenomic testing is widely available, but its utility has not yet been clearly established. (3) Other methods, such as whole exome and whole genome sequencing, will soon be clinically applicable. The need for informed genetic counseling in psychiatry is greater than ever before, knowledge in the field is rapidly growing, and genetic education should become an integral part of psychiatric training.
No figures extracted from this document.
1–20 of 23
Next →
| Name | Type |
|---|---|
| 22q11.2 deletion | variant |
| affected individual local | cohort |
| African-Americans | cohort |
| agranulocytosis local | phenotype |
| alcoholism | phenotype |
| antisocial personality disorder | phenotype |
| Asian descent local | cohort |
| autism | phenotype |
| autism spectrum disorder | phenotype |
| autism spectrum disorders | phenotype |
| behavioral disorders | phenotype |
| bipolar disorder | phenotype |
| bipolar I disorder | phenotype |
| blood | drug |
| brain | anatomy |
| carbamazepine | drug |
| children | cohort |
| chromosomal microarray local | drug |
| citalopram | drug |
| clozapine | drug |
| CNV | variant |
| common variants | cohort |
| complex diseases | phenotype |
| CYP2C19 local | gene |
| CYP2D6 | gene |
| de novo variant | variant |
| developmental conditions local | phenotype |
| epigenetic changes local | variant |
| first-degree relatives | cohort |
| fragile X testing local | drug |
| general population | cohort |
| genetic condition local | phenotype |
| genetic factors | cohort |
| genetic information local | drug |
| genetic variants | cohort |
| HbS local | variant |
| HLA variants local | variant |
| illness | phenotype |
| Independent genetic loci local | variant |
| intellectual disability | phenotype |
| major depressive disorder | phenotype |
| major psychiatric disorder local | phenotype |
| major psychiatric disorders | phenotype |
| medical disorders | phenotype |
| microarray | drug |
| neurodevelopmental disorder | phenotype |
| neuropsychiatric syndromes local | phenotype |
| parents | cohort |
| pharmacogenomic test local | drug |
| psychiatric disorders | phenotype |
| psychological issues local | phenotype |
| rare variant | cohort |
| saliva local | cohort |
| schizophrenia | phenotype |
| Schizophrenia GWAS1 local | cohort |
| siblings | cohort |
| sickle cell trait local | phenotype |
| skin | drug |
| slow metabolizer | phenotype |
| Specific medical syndromes local | phenotype |
| Stevens-Johnson syndrome | phenotype |
| variant | cohort |
| vortioxetine local | drug |
| whole exome sequencing | drug |
| Whole genome sequencing local | drug |
| XYY karyotype local | variant |
No uploaded files.
Not in any collection.
| Citation | PMID | DOI | Status |
|---|---|---|---|
| ACGME Program Requirements for Graduate Medical Education in Psychiatry. Accreditation Council for Graduate Medical Education website. http://www.acgme.org/Portals/0/PFAssets/ProgramRequirements/400_psychiatry_2017-07-01.pdf?ver=2017-05-25-083803-023. Effective July 1, 2017. | — | — | — |
| AltarCA, CarhartJ, AllenJD, Clinical utility of combinatorial pharmacogenomics-guided antidepressant therapy: evidence from three clinical studies. Mol Neuropsychiatry. 2015;1(3): 145–155.2760631210.1159/000430915PMC4996033 | — | — | — |
| AmareAT, SchubertKO, HouL, ; International Consortium on Lithium Genetics (ConLi+Gen). Association of polygenic score for schizophrenia and HLA antigen and inflammation genes with response to lithium in bipolar affective disorder: a genome-wide association study. JAMA Psychiatry. 2017;75(1):65–74.10.1001/jamapsychiatry.2017.3433PMC583353529121268 | — | — | — |
| AmentSA, SzelingerS, GlusmanG, ; Bipolar Genome Study. Rare variants in neuronal excitability genes influence risk for bipolar disorder. Proc Natl Acad Sci U S A 2015;112(11):3576–3581.2573087910.1073/pnas.1424958112PMC4371952 | — | — | — |
| American Academy of Neurology. Chromosomal Microarray Analysis for Intellectual Disabilities. American Academy of Neurology website https://www.aan.com/siteassets/home-page/tools-and-resources/practicing-neurologist—administrators/billing-and-coding/model-coverage-policies/15microarrayanalysismodel_tr.pdf. Effective August 20, 2013. | — | — | — |
| American Academy of Pediatrics. Initial Medical Evaluation of a Child Diagnosed With an Autism Spectrum Disorder [Council on Children with Disabilities fact sheet]. American Academy of Pediatrics website https://www.aap.org/en-us/Documents/cocd_fact_sheet_initialmedicine.pdf. Published 2013. | — | — | — |
| ArbuckleMR, TravisMJ, RossDA. Integrating a neuroscience perspective into clinical psychiatry today. JAMA Psychiatry. 2017;74(4):313–314.2827328810.1001/jamapsychiatry.2016.3849PMC5501322 | — | — | — |
| AustinJ, InglisA, HadjipavlouG. Genetic counseling for common psychiatric disorders: an opportunity for interdisciplinary collaboration. Am J Psychiatry. 2014;171(5):584–585.10.1176/appi.ajp.2014.13101421PMC411165424788289 | — | — | — |
| AustinJC, PalmerCG, Rosen-SheidleyB, Psychiatric disorders in clinical genetics II: individualizing recurrence risks. J Genet Couns. 2008;17(1):18–29.1807188810.1007/s10897-007-9121-4 | — | — | — |
| AustinJC, PeayHL. Applications and limitations of empiric data in provision of recurrence risks for schizophrenia: a practical review for healthcare professionals providing clinical psychiatric genetics consultations. Clin Genet. 2006;70(3):177–187.1692271710.1111/j.1399-0004.2006.00658.x | — | — | — |
| BakerK, RaymondFL, BassN. Genetic investigation for adults with intellectual disability: opportunities and challenges. Curr Opin Neurol. 2012;25(2):150–158.2235721710.1097/WCO.0b013e328351820e | — | — | — |
| BienvenuOJ, DavydowDS, KendlerKS. Psychiatric “diseases” versus behavioral disorders and degree of genetic influence. Psychol Med. 2011;41(1):33–40.2045988410.1017/S003329171000084XPMC10885735 | — | — | — |
| BoraskaV, FranklinCS, FloydJAB, ; Wellcome Trust Case Control Consortium 3. A genome-wide association study of anorexia nervosa. Mol Psychiatry. 2014;19(10):1085–1094.2451456710.1038/mp.2013.187PMC4325090 | — | — | — |
| Certification Examination in Psychiatry. American Board of Psychiatry and Neurology website. https://www.abpn.com/wp-content/uploads/2017/10/2018_Psychiatry_CERT_Content_Specifications.pdf. Published October 31, 2017. | — | — | — |
| ChampagneFA. Epigenetic legacy of parental experiences: dynamic and interactive pathways to inheritance. Dev Psychopathol. 2016;28(4pt2):1219–1228.2768771810.1017/S0954579416000808 | — | — | — |
| DeanL. Carbamazepine therapy and HLA genotypes In: PrattV, McLeodH, DeanL, , eds. Medical Genetics Summaries. Bethesda, MD: National Center for Biotechnology Information; 2012–2015.28520367 | — | — | — |
| DiggsLW. The sickle cell trait in relation to the training and assignment of duties in the armed forces, IV: considerations and recommendations. Aviat Space Environ Med. 1984;55(6):487–92.6466242 | — | — | — |
| FatemiSH, ClaytonPJ. The Medical Basis of Psychiatry. 3rd ed. New York, NY: Humana Press; 2016. | — | — | — |
| FinnCT, WilcoxMA, KorfBR, Psychiatric genetics: a survey of psychiatrists’ knowledge, opinions, and practice patterns. J Clin Psychiatry. 2005;66(7):821–830.1601389610.4088/jcp.v66n0703 | — | — | — |
| FoleyC, CorvinA, NakagomeS. Genetics of schizophrenia: ready to translate? Curr Psychiatry Rep. 2017;19(9):61.2874125510.1007/s11920-017-0807-5 | — | — | — |
| FullertonJM, KollerDL, EdenbergHJ, ; Bipolar High Risk Study Group, BiGS Consortium. Assessment of first and second degree relatives of individuals with bipolar disorder shows increased genetic risk scores in both affected relatives and young at-risk individuals. Am J Med Genet B Neuropsychiatr Genet. 2015;168(7):617–629.2617815910.1002/ajmg.b.32344PMC5054905 | — | — | — |
| GaglianoSA. It’s all in the brain: a review of available functional genomic annotations. Biol Psychiatry. 2017;81(6):478–483.2778891410.1016/j.biopsych.2016.08.011 | — | — | — |
| GelernterJ, KranzlerHR, ShervaR, Genome-wide association study of alcohol dependence: significant findings in African- and European-Americans including novel risk loci. Mol Psychiatry. 2014;19(1):41–49.2416640910.1038/mp.2013.145PMC4165335 | — | — | — |
| GershonES, Alliey-RodriguezN. New ethical issues for genetic counseling in common mental disorders. Am J Psychiatry. 2013;170(9):968–976.2389727310.1176/appi.ajp.2013.12121558 | — | — | — |
| GlattSJ, EverallIP, KremenWS, Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia. Proc Natl Acad Sci U S A. 2005;102(43):15533–15538.1622387610.1073/pnas.0507666102PMC1266138 | — | — | — |
| GWAS Catalog: the NHGRI-EPI catalog of published genome-wide association studies. http://www.ebi.ac.uk/gwas/downloads/summary-statistics.10.1093/nar/gkw1133PMC521059027899670 | — | — | — |
| HirschtrittME, BestermanAD, RossDA. Psychiatric pharmacogenomics: how close are we? Biol Psychiatry. 2016;80(8):e63–e65.2766306710.1016/j.biopsych.2016.08.007PMC5371713 | — | — | — |
| HoopJG, SavlaG, RobertsLW, The current state of genetics training in psychiatric residency: views of 235 US educators and trainees. Acad Psychiatry. 2010;34(2):109–114.2022401910.1176/appi.ap.34.2.109 | — | — | — |
| HowardDM, AdamsMJ, ShiraliM, Genome-wide association study of depression phenotypes in UK Biobank (n=322,580) identifies the enrichment of variants in excitatory synaptic pathways [published online August 1, 2018]. bioRxiv.10.1038/s41467-018-05310-5PMC611728530166530 | — | — | — |
| InglisA, MorrisE, AustinJ. Prenatal genetic counselling for psychiatric disorders. Prenat Diagn. 2017;37(1):6–13.2746603710.1002/pd.4878PMC5247258 | — | — | — |
| KarkJA, PoseyDM, SchumacherHR, Sickle-cell trait as a risk factor for sudden death in physical training. N Engl J Med. 1987;317(13):781–787.362719610.1056/NEJM198709243171301 | — | — | — |
| KevlesDK. In the Name of Eugenics 2nd ed. Cambridge, MA: Harvard University Press; 1995. | — | — | — |
| KopelmanL. Ethical controversies in medical research: the case of XYY screening. Perspect Biol Med. 1978;21(2):196–204.34737710.1353/pbm.1978.0039 | — | — | — |
| KorfBR, BerryAB, LimsonM, Framework for development of physician competencies in genomic medicine: report of the Competencies Working Group of the Inter-Society Coordinating Committee for Physician Education in Genomics. Genet Med. 2014;16(11):804–809.2476328710.1038/gim.2014.35 | — | — | — |
| LarssonH, AnckarsaterH, RâstamM, Childhood attention-deficit hyperactivity disorder as an extreme of a continuous trait: a quantitative genetic study of 8,500 twin pairs. J Child Psychol Psychiatry. 2012;53(1):73–80.2192380610.1111/j.1469-7610.2011.02467.x | — | — | — |
| Le HellardS, SteenVM. Genetic architecture of cognitive traits. Scand J Psychol. 2014;55(3):255–262.2460588610.1111/sjop.12112 | — | — | — |
| LeeSH, RipkeS, NealeBM, ; Cross-Disorder Group of the Psychiatric Genomics Consortium; International Inflammatory Bowel Disease Genetics Consortium (IIBDGC). Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet. 2013;45(9):984–994.2393382110.1038/ng.2711PMC3800159 | — | — | — |
| LiftonRJ. German doctors and the final solution. N Y Times Mag. 1986; 21:64–65, 70–75.11651851 | — | — | — |
| LiftonRJ. The Nazi Doctors: Medical Killing in the Psychology of Genocide, New Edition. Bethesda, MD: Basic Books; 2017. | — | — | — |
| MalhotraD, SebatJ. CNVs: harbingers of a rare variant revolution in psychiatric genetics. Cell. 2012;148(6):1223–1241.2242423110.1016/j.cell.2012.02.039PMC3351385 | — | — | — |
| ManolioTA, MurrayMF; Inter-Society Coordinating Committee for Practitioner Education in Genomics. The growing role of professional societies in educating clinicians in genomics. Genet Med. 2014;16(8):571–572.2450377910.1038/gim.2014.6 | — | — | — |
| MertensJ, WangQW, KimY, ; Pharmacogenomics of Bipolar Disorder Study. Differential responses to lithium in hyperexcitable neurons from patients with bipolar disorder. Nature. 2015;527(7576):95–99.2652452710.1038/nature15526PMC4742055 | — | — | — |
| MillerDT, AdamMP, AradhyaS, Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet. 2010;86(5):749–764.2046609110.1016/j.ajhg.2010.04.006PMC2869000 | — | — | — |
| MusunuruK, HaspelRL; Innovative Approaches to Education Working Group of the Inter-Society Coordinating Committee for Practitioner Education in Genomics. Improving genomic literacy among cardiovascular practitioners via a flipped-classroom workshop at a national meeting. Circ Cardiovasc Genet. 2016;9(3):287–290.2732965310.1161/CIRCGENETICS.116.001415PMC4918462 | — | — | — |
| NicolasG, CharbonnierC, CampionD. From common to rare variants: the genetic component of Alzheimer disease. Hum Hered. 2016;81(3):129–141.2800282510.1159/000452256 | — | — | — |
| OlfsonE, RossDA. Genes orchestrating brain function. Biol Psychiatry. 2017;82(3):e17–e19.2869373810.1016/j.biopsych.2017.06.003PMC5712901 | — | — | — |
| PaulsDL, AbramovitchA, RauchSL, Obsessive-compulsive disorder: an integrative genetic and neurobiological perspective. Nat Rev Neurosci. 2014;15(6):410–424.2484080310.1038/nrn3746 | — | — | — |
| Revised recommendations for Celexa (citalopram hydrobromide) related to a potential risk of abnormal heart rhythms with high doses [FDA Drug Safety Communication]. US Food and Drug Administration website. https://www.fda.gov/Drugs/DrugSafety/ucm297391.htm. Published March 28, 2012. | — | — | — |
| RischN. Linkage strategies for genetically complex traits, I: multilocus models. Am J Hum Genet. 1990;46(2):222–228.2301392PMC1684987 | — | — | — |
| RossDA, ArbuckleMR, TravisMJ, An integrated neuroscience perspective on formulation and treatment planning for posttraumatic stress disorder: an educational review. JAMA Psychiatry. 2017;74(4):407–415.2827329110.1001/jamapsychiatry.2016.3325PMC5504531 | — | — | — |
| RossDA, TravisMJ, ArbuckleMR. The future of psychiatry as clinical neuroscience: why not now? JAMA Psychiatry. 2015;72(5):413–414.2576089610.1001/jamapsychiatry.2014.3199PMC5347976 | — | — | — |
| SchaeferGB, MendelsohnNJ; Professional Practice and Guidelines Committee. Clinical genetics evaluation in identifying the etiology of autism spectrum disorders: 2013 guideline revisions. Genet Med. 2013;15(5):399–407.2351931710.1038/gim.2013.32 | — | — | — |
| Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511(7510):421–427.2505606110.1038/nature13595PMC4112379 | — | — | — |
| StahlE, ForstnerA, McQuillinA, Bipolar Disorder Working Group of the PGC. Genomewide association study identifies 30 loci associated with bipolar disorder [published online August 8, 2018]. bioRxiv.10.1038/s41588-019-0397-8PMC695673231043756 | — | — | — |
| TickB, BoltonP, HappéF, Heritability of autism spectrum disorders: a meta-analysis of twin studies. J Child Psychol Psychiatry. 2016;57(5):585–595.2670914110.1111/jcpp.12499PMC4996332 | — | — | — |
| Trintellix [package insert]. Deerfield, IL: Takeda Pharmaceuticals America, Inc; 2016. https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/204447s007lbl.pdf. | — | — | — |
| VolkmarF, SiegelM, Woodbury-SmithM, ; American Academy of Child and Adolescent Psychiatry (AACAP) Committee on Quality Issues (CQI). Practice parameter for the assessment and treatment of children and adolescents with autism spectrum disorder. J Am Acad Child Adolesc Psychiatry. 2014;53(2):237–257.2447225810.1016/j.jaac.2013.10.013 | — | — | — |
| VorstmanJAS, ParrJR, Moreno-De-LucaD, Autism genetics: opportunities and challenges for clinical translation. Nat Rev Genet. 2017;18(6):362–376.2826079110.1038/nrg.2017.4 | — | — | — |
| WaltonE, HassJ, LiuJ, Correspondence of DNA methylation between blood and brain tissue and its application to schizophrenia research. Schizophr Bull. 2016;42(2):406–414.2605637810.1093/schbul/sbv074PMC4753587 | — | — | — |
| WinnerJG, GoebertD, MatsuC, Training in psychiatric genomics during residency: a new challenge. Acad Psychiatry. 2010;34(2):115–118.2022402010.1176/appi.ap.34.2.115 | — | — | — |
| YangJ, LeeSH, GoddardME, GCTA: a tool for genome-wide complex trait analysis. Am J Hum Genet. 2011;88(1):76–82.2116746810.1016/j.ajhg.2010.11.011PMC3014363 | — | — | — |
| ZheutlinAB, RossDA. Polygenic risk scores: what are they good for? Biol Psychiatry. 2018;83(11):e51–e53.2975913310.1016/j.biopsych.2018.04.007PMC6696910 | — | — | — |
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Exploring community perspectives on autism genetics research: Indications of supportive views and educational needs. | de Wit MM et al. | — | 2026 | → |
| What do European clinical guidelines say about genetic testing for people with neuropsychiatric disorders? A scoping review. | Arican I et al. | — | 2026 | → |
| Equitable Collaboration Between LMIC and HIC Researchers, Part I: A Preliminary Framework for Capacity Building in Psychiatric Genetics Research. | Cabrera-Mendoza B et al. | — | 2025 | → |
| Long-Read Genome Sequencing in Clinical Psychiatry: <i>RFX3</i> Haploinsufficiency in a Hospitalized Adolescent With Autism, Intellectual Disability, and Behavioral Decompensation. | Mortazavi M et al. | — | 2025 | → |
| Obstacles, Opportunities, and Ethical Considerations for Genomic Investigations of Individuals Continuously Hospitalized with Treatment-resistant Schizophrenia. | Josiassen RC et al. | — | 2025 | → |
| Psychiatric Genetics in Clinical Practice: Essential Knowledge for Mental Health Professionals. | Besterman AD et al. | — | 2025 | → |
| Unresolved ethical issues of genetic counseling and testing in clinical psychiatry. | Perry J et al. | — | 2025 | → |
| Deletion of the <i>CYP2D6</i> gene as a likely explanation for the serious side effects of the antipsychotic drug pimozide: a case report. | Facal F et al. | — | 2023 | → |
| Spanish mental health residents' perspectives about residency education on the genetics of psychiatric disorders: A cross-sectional survey. | Saura P et al. | — | 2023 | → |
| The impact of receiving polygenic risk scores for alcohol use disorder on psychological distress, risk perception, and intentions to reduce drinking. | Driver MN et al. | — | 2023 | → |
| Barriers to genetic testing in clinical psychiatry and ways to overcome them: from clinicians' attitudes to sociocultural differences between patients across the globe. | Pinzón-Espinosa J et al. | — | 2022 | → |
| Catatonia in autism and other neurodevelopmental disabilities: a state-of-the-art review. | Moore S et al. | — | 2022 | → |
| Clinical opportunity awaits at the intersection of genomics and brain imaging. | Makowski C et al. | — | 2022 | → |
| From Genes to Therapy in Autism Spectrum Disorder. | Vorstman JAS et al. | — | 2022 | → |
| Gene-drug pairings for antidepressants and antipsychotics: level of evidence and clinical application. | Murphy LE et al. | — | 2022 | → |
| Genes To Mental Health (G2MH): A Framework to Map the Combined Effects of Rare and Common Variants on Dimensions of Cognition and Psychopathology. | Jacquemont S et al. | — | 2022 | → |
| High Polygenic Risk Scores Are Associated With Early Age of Onset of Alcohol Use Disorder in Adolescents and Young Adults at Risk. | Nurnberger JI et al. | — | 2022 | → |
| Psychiatric genetic counseling for patients with schizophrenia and their families. | Kotzé C et al. | — | 2022 | → |
| Psychiatric genomics, mental health equity, and intersectionality: A framework for research and practice. | Brown JEH et al. | — | 2022 | → |
| Putting Genetics to Work in the Psychiatric Clinic. | McMahon FJ | — | 2022 | → |
| A Review of DNA Risk Alleles to Determine Epigenetic Repair of mRNA Expression to Prove Therapeutic Effectiveness in Reward Deficiency Syndrome (RDS): Embracing "Precision Behavioral Management". | Blum K et al. | — | 2021 | → |
| Assessing Stakeholder Perceptions of the Utility of Genetic Information for the Clinical Care of Mental Health Disorders: We Have a Will but Need to See the Way. | Bourdon JL et al. | — | 2021 | → |
| Child and Adolescent Psychiatrists' Perceptions of Utility and Self-rated Knowledge of Genetic Testing Predict Usage for Autism Spectrum Disorder. | Soda T et al. | — | 2021 | → |
| Diagnostic genetic testing for neurodevelopmental psychiatric disorders: closing the gap between recommendation and clinical implementation. | Finucane BM et al. | — | 2021 | → |
| Genetic Advances in Autism. | Thapar A et al. | — | 2021 | → |
| In-vivo design feedback and perceived utility of a genetically-informed smoking risk tool among current smokers in the community. | Bourdon JL et al. | — | 2021 | → |
| Meta-analysis of probability estimates of worldwide variation of CYP2D6 and CYP2C19. | Koopmans AB et al. | — | 2021 | → |
| Increasing the Clinical Psychiatric Knowledge Base About Pathogenic Copy Number Variation. | Sullivan PF et al. | — | 2020 | → |
| Messaging in Biological Psychiatry: Misrepresentations, Their Causes, and Potential Consequences. | Dumas-Mallet E et al. | — | 2020 | → |
| Pan-european landscape of research into neurodevelopmental copy number variants: A survey by the MINDDS consortium. | Chawner SJRA et al. | — | 2020 | → |
| Re-examining the Ethics of Genetic Counselling in the Genomic Era. | Schupmann W et al. | — | 2020 | → |
| The Care of Patients With Complex Mood Disorders. | Cordner ZA et al. | — | 2020 | → |
| Using polygenic scores for identifying individuals at increased risk of substance use disorders in clinical and population samples. | Barr PB et al. | — | 2020 | → |
| 21st-Century Genetics in Psychiatric Residency Training: How Do We Get There? | Besterman AD et al. | — | 2019 | → |
| Dr Nurnberger and Colleagues Reply. | Nurnberger JI et al. | — | 2019 | → |
| Genetics and genetic counseling in psychiatry: Results from an opinion survey of professionals and users. | Martorell L et al. | — | 2019 | → |
| International Society of Psychiatric Genetics Ethics Committee: Issues facing us. | Lázaro-Muñoz G et al. | — | 2019 | → |
| Polygenic Prediction of Substance Use Disorders in Clinical and Population Samples | Barr PB et al. | — | 2019 | — |
| Polygenic risk scores in psychiatry: Will they be useful for clinicians? | Fullerton JM et al. | — | 2019 | → |